| 1 |
Mohtasham N, Najafi-Ghobadi K, Abbaszadeh H. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis. Cancer Rep (Hoboken) 2023;6:e1776. [PMID: 36573562 DOI: 10.1002/cnr2.1776] [Reference Citation Analysis]
|
| 2 |
Wang YY, Fang PT, Su CW, Chen YK, Huang JJ, Huang MY, Yuan SF. Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence. Oncol Lett 2021;21:450. [PMID: 33868488 DOI: 10.3892/ol.2021.12711] [Reference Citation Analysis]
|
| 3 |
Mozaffari HR, Rostamnia M, Sharifi R, Safaei M, Zavattaro E, Tadakamadla SK, Imani MM, Sadeghi M, Golshah A, Moradpoor H, Rezaei F, Omidpanah N, Hatami M. A PRISMA-compliant meta-analysis on association between X-ray repair cross complementing (XRCC1, XRCC2, and XRCC3) polymorphisms and oral cancer susceptibility. Gene 2021;781:145524. [PMID: 33631241 DOI: 10.1016/j.gene.2021.145524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Karunakaran K, Muniyan R. Genetic alterations and clinical dimensions of oral cancer: a review. Mol Biol Rep 2020;47:9135-48. [DOI: 10.1007/s11033-020-05927-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 5 |
Sánchez‐siles M, Aliaga‐sánchez A, Medina S, Adoamnei E, Fernández‐ruiz JA, Pelegrín‐hernández JP, Corno‐caparrós A, Rosa‐salazar V, Camacho‐alonso F. Genotyping of the C>T allele of rs16906252, predictor of O16‐methylguanine‐DNA methyltransferase (MGMT) promoter methylation status, in erosive atrophic lesions of oral lichen planus. Int J Dermatol 2019;58:1078-82. [DOI: 10.1111/ijd.14473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Mani RS, Mermershtain I, Abdou I, Fanta M, Hendzel MJ, Glover JNM, Weinfeld M. Domain analysis of PNKP-XRCC1 interactions: Influence of genetic variants of XRCC1. J Biol Chem 2019;294:520-30. [PMID: 30446622 DOI: 10.1074/jbc.RA118.004262] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 7 |
Hsueh Y, Lin Y, Chen W, Huang C, Shiue H, Pu Y, Chen C, Su C. The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 2017;332:1-7. [DOI: 10.1016/j.taap.2017.07.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 8 |
Yang CH, Lin YD, Yen CY, Chuang LY, Chang HW. A systematic gene-gene and gene-environment interaction analysis of DNA repair genes XRCC1, XRCC2, XRCC3, XRCC4, and oral cancer risk. OMICS 2015;19:238-47. [PMID: 25831063 DOI: 10.1089/omi.2014.0121] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Wu W, Liu L, Yin Z, Guan P, Li X, Zhou B. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis. PLoS One 2014;9:e86798. [PMID: 24497981 DOI: 10.1371/journal.pone.0086798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 10 |
Tong X, Yang J, Peng Y, Shen J, Xiong T, Zhang Y, Fan H. The association between the Arg280His polymorphism in the XRCC1 gene and the risk of hematological malignancies. Tumor Biol 2014;35:1687-93. [DOI: 10.1007/s13277-013-1232-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
